TG1050, an immunotherapeutic to treat chronic hepatitis B, induces robust T cells and exerts an antiviral effect in HBV-persistent mice
Perrine Martin, Clarisse Dubois, Emilie Jacquier, Sarah Dion, Maryline Mancini-Bourgine, Ophélie Godon, Roland Kratzer, Karine Lelu-Santolaria, Alexei Evlachev, Jean-François Meritet, Yasmin Schlesinger, Dominique Villeval, Jean-Marc Strub, Alain Van Dorsselaer, Jean-Baptiste Marchand, Michel Geist, Renée Brandely, Annie Findeli, Houda Boukhebza, Thierry Menguy, Nathalie Silvestre, Marie-Louise Michel, Geneviève Inchauspé
Gut Dec 2015, 64 (12) 1961-1971; DOI: 10.1136/gutjnl-2014-308041
